NORDICCELL ApS: Financial statements 2019
CVR: 27293972
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 6,803,198 and a net result of DKK 886,352 compared with DKK 1,512,902 the year before. That is an increase of 4% compared with the year before. Equity in the 2019 report amounted to DKK 2,259,430. The solvency ratio was 22.2%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 6,803,198
- Profit/Loss
- DKK 886,352
- Equity
- DKK 2,259,430
- Total Assets
- DKK 10,166,821
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 6.8 mio. | 886 t. | 2.3 mio. | 10 |
| 2018 | - | 6.5 mio. | 1.5 mio. | 2.9 mio. | 10 |
| 2017 | - | 7.1 mio. | 2.6 mio. | 4 mio. | 9 |
| 2016 | - | 5.6 mio. | 2 mio. | 1.3 mio. | 8 |
| 2015 | - | 4.8 mio. | 1.5 mio. | 1.3 mio. | 7 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.